Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease.
Wilson DC, Thomas AG, Croft NM, Newby E, Akobeng AK, Sawczenko A, Fell JM, Murphy MS, Beattie RM, Sandhu BK, Mitton SG; IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition; Casson D, Elawad M, Heuschkel R, Jenkins H, Johnson T, Macdonald S, Murch SH. Wilson DC, et al. J Pediatr Gastroenterol Nutr. 2010 Feb;50 Suppl 1:S14-34. doi: 10.1097/MPG.0b013e3181c92caa. J Pediatr Gastroenterol Nutr. 2010. PMID: 20081542 Review.
Natalizumab therapy for moderate to severe Crohn disease in adolescents.
Hyams JS, Wilson DC, Thomas A, Heuschkel R, Mitton S, Mitchell B, Daniels R, Libonati MA, Zanker S, Kugathasan S; International Natalizumab CD305 Trial Group. Hyams JS, et al. J Pediatr Gastroenterol Nutr. 2007 Feb;44(2):185-91. doi: 10.1097/01.mpg.0000252191.05170.e7. J Pediatr Gastroenterol Nutr. 2007. PMID: 17255829 Clinical Trial.
Enteral nutrition in children with Crohn's disease.
Heuschkel RB. Heuschkel RB. J Pediatr Gastroenterol Nutr. 2000 Nov;31(5):575. doi: 10.1097/00005176-200011000-00024. J Pediatr Gastroenterol Nutr. 2000. PMID: 11144448 No abstract available.
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R; REACH Study Group. Hyams J, et al. Gastroenterology. 2007 Mar;132(3):863-73; quiz 1165-6. doi: 10.1053/j.gastro.2006.12.003. Epub 2006 Dec 3. Gastroenterology. 2007. PMID: 17324398 Clinical Trial.
87 results